Vabomere Injection, Powder, For Solution
Product Images NDC 70842-120

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Vabomere (NDC 70842-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Melinta Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Vabomere 01)

Chemical structure of Meropenem-Vaborbactam, the active ingredient in VABOMERE injection powder for solution. The structure shows the molecular arrangement including labeled groups such as hydroxyl, amide, sulfur, and hydrated water molecules (3H2O).*

FDA Label Image

Chemical Structure (Vabomere 02)

Chemical structure of Meropenem-Vaborbactam, the active ingredient in the VABOMERE injection powder for solution. The diagram displays molecular bonds and rings characteristic of this compound.*

FDA Label Image

Principal Display Panel (2 g Vial Carton)

VABOMERE (meropenem and vaborbactam) injection powder for solution, 2 g per vial, by Melinta Therapeutics. The label states intravenous use, single dose only, and discarding unused portions. Each vial contains meropenem 1 g (equivalent to 1.14 g meropenem trihydrate) and vaborbactam 1 g. Packaging contains 6 single dose 2 g vials. Storage instructions and constitution/dilution directions are noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.